Personal information

Verified email domains

B cells, Lymphoma, Immunodeficiency, Inborn errors of immunity, Immunoglobulin class switching, Somatic hypermutation, Caner genetics, COVID-19
Sweden

Activities

Employment (5)

Karolinska Institutet: Stockholm, SE

2023-07 to present | Professor, head of the Immunology Division (Department of Medical Biophysics and Biochemistry)
Employment
Source: Self-asserted source
Qiang Pan-Hammarström

Karolinska Institutet: Stockholm, SE

2018-04 to 2023-06 | Professor (Department of Biosciences and Nutrition )
Employment
Source: Self-asserted source
Qiang Pan-Hammarström

Karolinska Institutet: Stockholm, SE

2011-10 to 2018-03 | Professor (Department of Laboratory Medicine)
Employment
Source: Self-asserted source
Qiang Pan-Hammarström

Karolinska Institutet: Stockholm, SE

2004-08 to 2011-09 | Associate Professor (Department of Laboratory Medicine)
Employment
Source: Self-asserted source
Qiang Pan-Hammarström

Karolinska Institutet: Stockholm, SE

2004-01 to 2004-07 | Assistant Professor (Department of Laboratory Medicine)
Employment
Source: Self-asserted source
Qiang Pan-Hammarström

Education and qualifications (3)

Harvard Business School: Boston, MA, US

2017-11 to 2019-07 | Program of leadership development, EMBA alternative
Education
Source: Self-asserted source
Qiang Pan-Hammarström

Karolinska Institutet: Stockholm, SE

1994-08 to 1999-11-26 | PhD in Molecular Immunology
Education
Source: Self-asserted source
Qiang Pan-Hammarström

Sun Yat-Sen University: Guangzhou, Guangdong, CN

1988-08 to 1993-07 | Bachelor degree in Medicine
Education
Source: Self-asserted source
Qiang Pan-Hammarström

Peer review (22 reviews for 14 publications/grants)

Review activity for Blood cancer journal. (1)
Review activity for Cancer cell. (1)
Review activity for Cancer communications. (1)
Review activity for Cell death and differentiation. (1)
Review activity for Cell discovery. (2)
Review activity for HemaSphere. (1)
Review activity for Journal of clinical immunology. (2)
Review activity for Journal of clinical immunology. (1)
Review activity for Journal of infectious diseases. (2)
Review activity for Nature (2)
Review activity for Nature communications (1)
Review activity for Signal transduction and targeted therapy. (2)
Review activity for The Journal of experimental medicine. (1)
Review activity for The journal of experimental medicine. (4)